Cancer incidence in people with hepatitis B or C infection: A large community-based linkage study

Journal of Hepatology

Volumn 45, Issue 2, 2006, Pages 197-203

  Amin, Janaki ^a   Dore, Gregory J ^a   O'Connell, Dianne L ^b   Bartlett, Mark ^c   Tracey, Elizabeth ^d   Kaldor, John M ^a   Law, Matthew G ^a  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

^b CANCER RESEARCH DIVISION   (Australia)

^c New South Wales Government   (Australia)

^d New South Wales Cancer Registry   (Australia)

Author keywords

Cancer; Epidemiology; Hepatitis B; Hepatitis C; Hepatocellular carcinoma; Linkage

Indexed keywords

ADULT; ARTICLE; BURKITT LYMPHOMA; CANCER INCIDENCE; CANCER REGISTRY; CANCER RISK; COHORT ANALYSIS; COMMUNITY; CONFIDENCE INTERVAL; CONTROLLED STUDY; FEMALE; HEPATITIS B; HEPATITIS B VIRUS; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; LIVER CARCINOMA; LYMPHOPROLIFERATIVE DISEASE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROBABILITY; STANDARDIZATION; SUPERINFECTION;

ADULT; CARCINOMA, HEPATOCELLULAR; FEMALE; HEPATITIS B; HEPATITIS C; HUMANS; INCIDENCE; LIVER NEOPLASMS; MALE; MEDICAL RECORD LINKAGE; NEW SOUTH WALES; RETROSPECTIVE STUDIES; RISK FACTORS;

EID: 33745699346     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jhep.2006.02.014     Document Type: Article

References (49)

1. Beasley R.P., Hwang L.Y., Lin C.C., and Chien C.S. Hepatocellular carcinoma and hepatitis B virus. A prospective study of 22 707 men in Taiwan. Lancet 2 (1981) 1129-1133
2. Simonetti R.G., Cottone M., Craxi A., Pagliaro L., Rapicetta M., Chionne P., et al. Prevalence of antibodies to hepatitis C virus in hepatocellular carcinoma. Lancet 2 (1989) 1338
3. Colombo M., Kuo G., Choo Q.L., Donato M.F., Del Ninno E., Tommasini M.A., et al. Prevalence of antibodies to hepatitis C virus in Italian patients with hepatocellular carcinoma. Lancet 2 (1989) 1006-1008
4. Bruix J., Barrera J.M., Calvet X., Ercilla G., Costa J., Sanchez-Tapias J.M., et al. Prevalence of antibodies to hepatitis C virus in Spanish patients with hepatocellular carcinoma and hepatic cirrhosis. Lancet 2 (1989) 1004-1006
5. Shi J., Zhu L., Liu S., and Xie W.F. A meta-analysis of case-control studies on the combined effect of hepatitis B and C virus infections in causing hepatocellular carcinoma in China. Br J Cancer 92 (2005) 607-612
6. Pasquinelli C., Laure F., Chatenoud L., Beaurin G., Gazengel C., Bismuth H., et al. Hepatitis B virus DNA in mononuclear blood cells. A frequent event in hepatitis B surface antigen-positive and -negative patients with acute and chronic liver disease. J Hepatol 3 (1986) 95-103
7. Ferri C., Monti M., La Civita L., Longombardo G., Greco F., Pasero G., et al. Infection of peripheral blood mononuclear cells by hepatitis C virus in mixed cryoglobulinemia. Blood 82 (1993) 3701-3704
8. Pawlotsky J.M., Roudot-Thoraval F., Simmonds P., Mellor J., Ben Yahia M.B., Andre C., et al. Extrahepatic immunologic manifestations in chronic hepatitis C and hepatitis C virus serotypes. Ann Intern Med 122 (1995) 169-173
9. Kuniyoshi M., Nakamuta M., Sakai H., Enjoji M., Kinukawa N., Kotoh K., et al. Prevalence of hepatitis B or C virus infections in patients with non-Hodgkin's lymphoma. J Gastroenterol Hepatol 16 (2001) 215-219
10. Negri E., Little D., Boiocchi M., La Vecchia C., and Franceschi S. B-cell non-Hodgkin's lymphoma and hepatitis C virus infection: a systematic review. Int J Cancer 111 (2004) 1-8
11. Montella M., Crispo A., de Bellis G., Izzo F., Frigeri F., Ronga D., et al. HCV and cancer: a case-control study in a high-endemic area. Liver 21 (2001) 335-341
12. NSW Health. Notifiable diseases response protocols for NSW Public Health Units. In: , editor; 2004.
13. World Health Organization. International statistical classification of diseases and related health problems. 10th revision. Geneva: World Health Organization; 1992.
14. Jaro M.A. Probabilistic linkage of large public health data files. Stat Med 14 (1995) 491-498
15. AUTOMATCH. In: Generalized record linkage system. Maryland; 1997.
16. Breslow N.E., and Day N.E. The design and analysis of cohort studies. In: Heseltine E. (Ed). Statistical methods in cancer research (1987), Oxford University Press, Lyon 48-81
17. Australian Bureau of Statistics. Population by age and sex, Australian States and Territories. Canberra: Australian Bureau of Statistics; 2003.
18. Grulich A.E., Wan X., Law M.G., Coates M., and Kaldor J.M. Risk of cancer in people with AIDS. AIDS 13 (1999) 839-843
19. Daling J.R., Weiss N.S., Hislop T.G., Maden C., Coates R.J., Sherman K.J., et al. Sexual practices, sexually transmitted diseases, and the incidence of anal cancer. N Engl J Med 317 (1987) 973-977
20. Madeddu D, Prestage G, Grierson J, Smith A, Richters J, Ferris J, et al. How many homosexual men are there in inner city Sydney? The inner east and inner west gay 'ghettos'. In: 15th annual conference Australasian society for HIV medicine, 2003. Cairns; 2003.
21. Law M.G., Dore G.J., Bath N., Thompson S., Crofts N., Dolan K., et al. Modelling hepatitis C virus incidence, prevalence and long-term sequelae in Australia, 2001. Int J Epidemiol 32 (2003) 717-724
22. Kaldor J.M., Plant A.J., Thompson S.C., Longbottom H., and Rowbottom J. The incidence of hepatitis B infection in Australia: an epidemiological review. Med J Aust 165 (1996) 322-326
23. IARC. Hepatitis viruses. Geneva: World Health Organization; 1994.
24. O'Sullivan B.G., Gidding H.F., Law M., Kaldor J.M., Gilbert G.L., and Dore G.J. Estimates of chronic hepatitis B virus infection in Australia, 2000. Aust N Z J Public Health 28 (2004) 212-216
25. Davila J.A., Morgan R.O., Shaib Y., McGlynn K.A., and El-Serag H.B. Hepatitis C infection and the increasing incidence of hepatocellular carcinoma: a population-based study. Gastroenterology 127 (2004) 1372-1380
26. Tanaka H., Tsukuma H., Yamano H., Oshima A., and Shibata H. Prospective study on the risk of hepatocellular carcinoma among hepatitis C virus-positive blood donors focusing on demographic factors, alanine aminotransferase level at donation and interaction with hepatitis B virus. Int J Cancer 112 (2004) 1075-1080
27. Fattovich G., Stroffolini T., Zagni I., and Donato F. Hepatocellular carcinoma in cirrhosis: incidence and risk factors. Gastroenterology 127 (2004) S35-S50
28. Donato F., Boffetta P., and Puoti M. A meta-analysis of epidemiological studies on the combined effect of hepatitis B and C virus infections in causing hepatocellular carcinoma. Int J Cancer 75 (1998) 347-354
29. Gisbert J.P., Garcia-Buey L., Pajares J.M., and Moreno-Otero R. Prevalence of hepatitis C virus infection in B-cell non-Hodgkin's lymphoma: systematic review and meta-analysis. Gastroenterology 125 (2003) 1723-1732
30. Matsuo K., Kusano A., Sugumar A., Nakamura S., Tajima K., and Mueller N.E. Effect of hepatitis C virus infection on the risk of non-Hodgkin's lymphoma: a meta-analysis of epidemiological studies. Cancer Sci 95 (2004) 745-752
31. Ohsawa M., Shingu N., Miwa H., Yoshihara H., Kubo M., Tsukuma H., et al. Risk of non-Hodgkin's lymphoma in patients with hepatitis C virus infection. Int J Cancer 80 (1999) 237-239
32. Duberg A.S., Nordstrom M., Torner A., Reichard O., Strauss R., Janzon R., et al. Non-Hodgkin's lymphoma and other nonhepatic malignancies in Swedish patients with hepatitis C virus infection. Hepatology 41 (2005) 652-659
33. Cote T.R., Biggar R.J., Rosenberg P.S., Devesa S.S., Percy C., Yellin F.J., et al. Non-Hodgkin's lymphoma among people with AIDS: incidence, presentation and public health burden. AIDS/Cancer Study Group. Int J Cancer 73 (1997) 645-650
34. Ferri C., La Civita L., Monti M., Longombardo G., Greco F., Pasero G., et al. Can type C hepatitis infection be complicated by malignant lymphoma?. Lancet 346 (1995) 1426-1427
35. Mazzaro C., Zagonel V., Monfardini S., Tulissi P., Pussini E., Fanni M., et al. Hepatitis C virus and non-Hodgkin's lymphomas. Br J Haematol 94 (1996) 544-550
36. Mele A., Pulsoni A., Bianco E., Musto P., Szklo A., Sanpaolo M.G., et al. Hepatitis C virus and B-cell non-Hodgkin lymphomas: an Italian multicenter case-control study. Blood 102 (2003) 996-999
37. Zuckerman E., Zuckerman T., Levine A.M., Douer D., Gutekunst K., Mizokami M., et al. Hepatitis C virus infection in patients with B-cell non-Hodgkin lymphoma. Ann Intern Med 127 (1997) 423-428
38. Engels E.A., Chatterjee N., Cerhan J.R., Davis S., Cozen W., Severson R.K., et al. Hepatitis C virus infection and non-Hodgkin lymphoma: results of the NCI-SEER multi-center case-control study. Int J Cancer 111 (2004) 76-80
39. Silvestri F., Barillari G., Fanin R., Pipan C., Falasca E., Salmaso F., et al. Hepatitis C virus infection among cryoglobulinemic and non-cryoglobulinemic B-cell non-Hodgkin's lymphomas. Haematologica 82 (1997) 314-317
40. Germanidis G., Haioun C., Pourquier J., Gaulard P., Pawlotsky J.M., Dhumeaux D., et al. Hepatitis C virus infection in patients with overt B-cell non-Hodgkin's lymphoma in a French center. Blood 93 (1999) 1778-1779
41. Harris N.L., Jaffe E.S., Stein H., Banks P.M., Chan J.K., Cleary M.L., et al. A revised European-American classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Group. Blood 84 (1994) 1361-1392
42. Harris N.L., Jaffe E.S., Diebold J., Flandrin G., Muller-Hermelink H.K., and Vardiman J. Lymphoma classification - from controversy to consensus: the R.E.A.L. and WHO classification of lymphoid neoplasms. Ann Oncol 11 (2000) 3-10
43. Weng W.K., and Levy S. Hepatitis C virus (HCV) and lymphomagenesis. Leuk Lymphoma 44 (2003) 1113-1120
44. Dore G.J., Law M., MacDonald M., and Kaldor J.M.H. Epidemiology of hepatitis C virus infection in Australia. J Clin Virol 26 (2003) 171-184
45. In: Muir C.S., Waterhouse J., Mack T., Powell J., and Whelan S. (Eds). Cancer incidence in five continents vol. V (1987), IARC, Lyon
46. Britton W.J., Parsons C., Gallagher N.D., Cossart Y., and Burnett L. Risk factors associated with hepatitis B infection in antenatal patients. Aust N Z J Med 15 (1985) 641-644
47. Pesce A.F., Crewe E.B., and Cunningham A.L. Should all pregnant women be screened for hepatitis B surface antigen?. Med J Aust 150 (1989) 19-21
48. Poynard T., Bedossa P., and Opolon P. Natural history of liver fibrosis progression in patients with chronic hepatitis C. The OBSVIRC, METAVIR, CLINIVIR, and DOSVIRC groups. Lancet 349 (1997) 825-832
49. Seeff L.B., Miller R.N., Rabkin C.S., Buskell-Bales Z., Straley-Eason K.D., Smoak B.L., et al. 45-year follow-up of hepatitis C virus infection in healthy young adults. Ann Intern Med 132 (2000) 105-111